The effects of influenza vaccination of health care workers in nursing homes: insights from a mathematical model

Carline van den Dool, Marc J M Bonten, Eelko Hak, Janneke C M Heijne, Jacco Wallinga, Carline van den Dool, Marc J M Bonten, Eelko Hak, Janneke C M Heijne, Jacco Wallinga

Abstract

Background: Annual influenza vaccination of institutional health care workers (HCWs) is advised in most Western countries, but adherence to this recommendation is generally low. Although protective effects of this intervention for nursing home patients have been demonstrated in some clinical trials, the exact relationship between increased vaccine uptake among HCWs and protection of patients remains unknown owing to variations between study designs, settings, intensity of influenza seasons, and failure to control all effect modifiers. Therefore, we use a mathematical model to estimate the effects of HCW vaccination in different scenarios and to identify a herd immunity threshold in a nursing home department.

Methods and findings: We use a stochastic individual-based model with discrete time intervals to simulate influenza virus transmission in a 30-bed long-term care nursing home department. We simulate different levels of HCW vaccine uptake and study the effect on influenza virus attack rates among patients for different institutional and seasonal scenarios. Our model reveals a robust linear relationship between the number of HCWs vaccinated and the expected number of influenza virus infections among patients. In a realistic scenario, approximately 60% of influenza virus infections among patients can be prevented when the HCW vaccination rate increases from 0 to 1. A threshold for herd immunity is not detected. Due to stochastic variations, the differences in patient attack rates between departments are high and large outbreaks can occur for every level of HCW vaccine uptake.

Conclusions: The absence of herd immunity in nursing homes implies that vaccination of every additional HCW protects an additional fraction of patients. Because of large stochastic variations, results of small-sized clinical trials on the effects of HCW vaccination should be interpreted with great care. Moreover, the large variations in attack rates should be taken into account when designing future studies.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Influenza Virus Attack Rates among…
Figure 1. Influenza Virus Attack Rates among Patients for Increasing Health Care Worker Vaccination Rates
(A) Increased vaccination of HCWs decreases the expected influenza virus attack rate among patients. Squares indicate the mean attack rates, dashed lines the median attack rates, and light blue boxes the 2.5th to 97.5th percentiles. (B–D) The distribution of the influenza virus attack rates among patients shifts to the left when vaccine uptake among HCWs is increased from 0, to 0.5, and 1 for (B), (C), and (D), respectively. Each distribution is based on 5,000 simulations.
Figure 2. Effects of Increased Health Care…
Figure 2. Effects of Increased Health Care Worker Vaccination on Influenza Virus Attack and Introduction Rates
Increased vaccination of health care workers (HCWs) reduces the influenza virus attack rate among HCWs. It also reduces the rate of introduction of influenza virus into the patient population and the attack rate among patients following an introduction. As a consequence it reduces the total attack rate among patients. All relationships appear linear.
Figure 3. Effects of Increased Health Care…
Figure 3. Effects of Increased Health Care Worker Vaccination on Patient Attack Rates in Different Scenarios
For all scenarios under study, the influenza virus attack rate among patient decreases in an approximately linear way when the health care worker vaccination rate is increased. (A) The expected attack rates for the open and closed departments, where patients have many or no contacts with individuals from the community, respectively. (B) The attack rates for seasons with high (15% community attack rate) and low (5% community attack rate) influenza virus activity. (C) The attack rates for departments with high and low HCW/patient ratios.

References

    1. Fiore AE, Shay DK, Haber P, Iskander JK, Uyeki TM, et al. Prevention and Control of Influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep. 2007;56:1–54.
    1. Burls A, Jordan R, Barton P, Olowokure B, Wake B, et al. Vaccinating healthcare workers against influenza to protect the vulnerable–is it a good use of healthcare resources? A systematic review of the evidence and an economic evaluation. Vaccine. 2006;24:4212–4221.
    1. Carman WF, Elder AG, Wallace LA, McAulay K, Walker A, et al. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: a randomised controlled trial. Lancet. 2000;355:93–97.
    1. Hayward AC, Harling R, Wetten S, Johnson AM, Munro S, et al. Effectiveness of an influenza vaccine programme for care home staff to prevent death, morbidity, and health service use among residents: cluster randomised controlled trial. BMJ. 2006;333:1241.
    1. Potter J, Stott DJ, Roberts MA, Elder AG, O'Donnell B, et al. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients. J Infect Dis. 1997;175:1–6.
    1. Kimura AC, Nguyen CN, Higa JI, Hurwitz EL, Vugia DJ. The effectiveness of vaccine day and educational interventions on influenza vaccine coverage among health care workers at long-term care facilities. Am J Public Health. 2007;97:684–690.
    1. Song JY, Park CW, Jeong HW, Cheong HJ, Kim WJ, et al. Effect of a hospital campaign for influenza vaccination of healthcare workers. Infect Control Hosp Epidemiol. 2006;27:612–617.
    1. Polgreen PM, Chen Y, Beekmann S, Srinivasan A, Neill MA, et al. Elements of influenza vaccination programs that predict higher vaccination rates: results of an emerging infections network survey. Clin Infect Dis. 2008;46:14–19.
    1. McLennan S, Gillett G, Celi LA. Healer, heal thyself: health care workers and the influenza vaccination. Am J Infect Control. 2008;36:1–4.
    1. Verweij M, van Den HM. Influenza vaccination rates and informed consent in Dutch nursing homes: survey of nursing home physicians. BMJ. 2002;324:328.
    1. Anderson R, May RM. Infectious diseases of humans: dynamics and control. New York: Oxford University Press; 1991.
    1. Diekmann O, Heesterbeek JAP. Mathematical epidemiology of infectious diseases: model building, analysis and interpretation. Chichester: John Wiley & Sons Ltd; 2000.
    1. [Anonymous] Doelmatigheid verpleeghuizen in relatie tot verantwoorde zorg onderzocht. Utrecht: College Tarieven Gezondheidszorg/Zorgautoriteit i.o; 2006. Available: . Accessed 23 September 2008.
    1. [Anonymous] Arcares jaarverslag 2005. Utrecht: Dutch National Association for Nursing and Care; 2006.
    1. Hirotsu N, Ikematsu H, Iwaki N, Kawai N, Shigematsu T, et al. Effects of antiviral drugs on viral detection in influenza patients and on the sequential infection to their family members–serial examination by rapid diagnosis (Capilia) and virus culture. International Congress Series. 2004;1263:105–108.
    1. Wallinga J, Lipsitch M. How generation intervals shape the relationship between growth rates and reproductive numbers. Proc Biol Sci. 2007;274:599–604.
    1. Rvachev A, Longini IM. A mathematical model for the global spread of influenza. Mathematical Biosciences. 1985;75:3–22.
    1. Cauchemez S, Valleron AJ, Boelle PY, Flahault A, Ferguson NM. Estimating the impact of school closure on influenza transmission from Sentinel data. Nature. 2008;452:750–754.
    1. Webster RG. Immunity to influenza in the elderly. Vaccine. 2000;18:1686–1689.
    1. Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine. 2007;25:3066–3069.
    1. McKay MD, Conover WJ, Beckman RJ. A comparison of three methods for selecting values of input variables in the analysis of output from a computer code. Technometrics. 1979;21:239–246.
    1. Blower SM, Hartel D, Dowlatabadi H, Anderson RM, May RM. Drugs, sex and HIV: a mathematical model for New York City. Philos Trans R Soc Lond B Biol Sci. 1991;331:171–187.
    1. Blower SM, McLean AR, Porco TC, Small PM, Hopewell PC, et al. The intrinsic transmission dynamics of tuberculosis epidemics. Nat Med. 1995;1:815–821.
    1. Blower SM, Dowlatabadi H. Sensitivity and uncertainty analysis of complex-models of disease transmission - an Hiv model, as an example. Int Stat Rev. 1994;62:229–243.
    1. Sanchez MA, Blower SM. Uncertainty and sensitivity analysis of the basic reproductive rate—Tuberculosis as an example. Am J Epidemiol. 1997;145:1127–1137.
    1. Jefferson T, Rivetti D, Di Pietrantonj C, Rivetti A, Demicheli V. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst Rev. 2007. CD001269.
    1. Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, et al. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet. 2005;366:1165–1174.
    1. Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med. 2007;357:1373–1381.
    1. Kingston BJ, Wright CV., Jr. Influenza in the nursing home. Am Fam Physician. 2002;65:72.
    1. de Klerk M. Ouderen in Instellingen. The Hague: SCP; 2005. pp. 26–29.
    1. Kerry SM, Bland JM. Trials which randomize practices II: sample size. Fam Pract. 1998;15:84–87.
    1. Florey CD. Sample size for beginners. BMJ. 1993;306:1181–1184.
    1. Halloran ME, Hayden FG, Yang Y, Longini IM, Jr., Monto AS. Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials. Am J Epidemiol. 2007;165:212–221.
    1. van Elden LJ, van Essen GA, Boucher CA, van Loon AM, Nijhuis M, et al. Clinical diagnosis of influenza virus infection: evaluation of diagnostic tools in general practice. Br J Gen Pract. 2001;51:630–634.
    1. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–3247.
    1. Oshitani H, Saito R, Seki N, Tanabe N, Yamazaki O, et al. Influenza vaccination levels and influenza-like illness in long-term-care facilities for elderly people in Niigata, Japan, during an influenza A (H3N2) epidemic. Infect Control Hosp Epidemiol. 2000;21:728–730.
    1. Thomas RE, Jefferson TO, Demicheli V, Rivetti D. Influenza vaccination for health-care workers who work with elderly people in institutions: a systematic review. Lancet Infect Dis. 2006;6:273–279.
    1. Drinka PJ, Gravenstein S, Krause P, Schilling M, Miller BA, et al. Outbreaks of influenza A and B in a highly immunized nursing home population. J Fam Pract. 1997;45:509–514.
    1. Lakatos E. Sample size determination for clinical trials. In: Armitage P, Colton T, editors. Encyclopedia of biostatistics. Chichester: Wiley; 1998. p. 3903.

Source: PubMed

3
購読する